JOSEPH LUBEGA

Concepts (155)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
3
2023
2789
0.840
Why?
Medical Oncology
2
2021
213
0.830
Why?
HIV Infections
4
2022
1897
0.830
Why?
Hematologic Diseases
2
2025
76
0.810
Why?
Thrombocytosis
1
2022
34
0.790
Why?
Healthcare Disparities
2
2024
431
0.790
Why?
Cerebellar Neoplasms
1
2024
285
0.730
Why?
Medulloblastoma
1
2024
340
0.720
Why?
Acquired Immunodeficiency Syndrome
1
2022
235
0.720
Why?
Thrombocytopenia
1
2022
227
0.700
Why?
Malnutrition
1
2022
204
0.650
Why?
Anemia
1
2022
340
0.610
Why?
Hematology
1
2018
37
0.610
Why?
Immunophenotyping
1
2018
330
0.580
Why?
Global Health
2
2021
558
0.550
Why?
Child
22
2025
24463
0.550
Why?
Leukemia, Myeloid, Acute
2
2021
538
0.540
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2021
779
0.530
Why?
Flow Cytometry
1
2018
803
0.520
Why?
Africa South of the Sahara
5
2025
115
0.490
Why?
Hematologic Neoplasms
1
2018
284
0.490
Why?
Uganda
3
2024
68
0.430
Why?
Anemia, Sickle Cell
3
2022
339
0.430
Why?
Lamivudine
2
2022
25
0.410
Why?
Capacity Building
2
2025
24
0.400
Why?
Developing Countries
2
2024
269
0.360
Why?
Pediatrics
2
2025
1155
0.350
Why?
Histiocytosis, Langerhans-Cell
2
2024
225
0.300
Why?
Humans
27
2025
124822
0.270
Why?
Case-Control Studies
3
2022
3288
0.270
Why?
Lymphoma, Non-Hodgkin
2
2016
164
0.240
Why?
CD4 Lymphocyte Count
2
2022
232
0.240
Why?
Acute Kidney Injury
2
2022
634
0.240
Why?
Retrospective Studies
6
2024
16296
0.220
Why?
Prognosis
2
2022
4615
0.210
Why?
Nevirapine
1
2022
15
0.210
Why?
Platelet Count
1
2022
136
0.200
Why?
Risk Factors
5
2022
10275
0.190
Why?
Pancytopenia
1
2021
40
0.180
Why?
Injection Site Reaction
1
2021
7
0.180
Why?
Child, Preschool
8
2024
14054
0.170
Why?
Rituximab
1
2021
157
0.170
Why?
Global Burden of Disease
1
2019
25
0.170
Why?
Lymphoproliferative Disorders
1
2021
224
0.170
Why?
Anaphylaxis
1
2021
80
0.170
Why?
Bone Marrow Cells
1
2021
261
0.160
Why?
Immunologic Factors
1
2021
174
0.160
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
145
0.160
Why?
Neutropenia
1
2021
200
0.160
Why?
Burkitt Lymphoma
1
2020
144
0.160
Why?
Wilms Tumor
1
2019
113
0.150
Why?
Osteopontin
1
2018
49
0.150
Why?
Patient Care
1
2018
99
0.150
Why?
Incidence
3
2020
3144
0.140
Why?
Adolescent
8
2024
19333
0.140
Why?
Poverty
1
2021
417
0.140
Why?
Health Status Disparities
1
2019
227
0.140
Why?
Sepsis
1
2021
479
0.140
Why?
Male
12
2024
61314
0.130
Why?
Lymphoma
2
2021
324
0.130
Why?
Proto-Oncogene Proteins B-raf
1
2018
170
0.130
Why?
Health Services Accessibility
1
2021
607
0.130
Why?
Kaplan-Meier Estimate
1
2018
1028
0.130
Why?
Air Pollutants, Radioactive
1
2015
5
0.130
Why?
Infant
6
2021
12488
0.130
Why?
Radon
1
2015
11
0.130
Why?
Young Adult
5
2021
8993
0.120
Why?
Fellowships and Scholarships
1
2018
277
0.120
Why?
Air Pollution, Indoor
1
2015
30
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1237
0.120
Why?
Kidney Neoplasms
1
2019
431
0.120
Why?
Neurodegenerative Diseases
1
2018
252
0.120
Why?
Female
11
2024
66580
0.120
Why?
Sarcoma, Kaposi
1
2016
120
0.120
Why?
Hodgkin Disease
1
2016
293
0.110
Why?
Education, Medical, Graduate
1
2018
515
0.110
Why?
T-Lymphocytes
1
2021
1709
0.100
Why?
Pericardial Effusion
1
2012
65
0.100
Why?
Stomatitis, Aphthous
1
2011
3
0.100
Why?
Respiratory Syncytial Viruses
1
2012
147
0.090
Why?
Heart Septal Defects, Ventricular
1
2012
133
0.090
Why?
Atrioventricular Block
1
2011
39
0.090
Why?
Creatinine
2
2022
390
0.090
Why?
Respiratory Insufficiency
1
2012
232
0.080
Why?
Respiratory Syncytial Virus Infections
1
2012
341
0.080
Why?
Brain Neoplasms
1
2018
1241
0.080
Why?
Diagnosis, Differential
3
2021
1894
0.070
Why?
Proportional Hazards Models
2
2021
1351
0.070
Why?
Herpesvirus 4, Human
2
2021
674
0.060
Why?
Cardiac Surgical Procedures
1
2012
1115
0.050
Why?
Lipocalin-2
1
2022
29
0.050
Why?
Lipocalins
1
2022
30
0.050
Why?
Acute-Phase Proteins
1
2022
47
0.050
Why?
Child, Hospitalized
1
2022
72
0.050
Why?
Leukoencephalopathy, Progressive Multifocal
1
2021
18
0.050
Why?
Long Term Adverse Effects
1
2021
12
0.050
Why?
Biomarkers
2
2022
3063
0.050
Why?
Agammaglobulinemia
1
2021
39
0.040
Why?
Lymphocyte Count
1
2021
117
0.040
Why?
Nephrotic Syndrome
1
2021
46
0.040
Why?
Autoimmune Diseases of the Nervous System
1
2021
33
0.040
Why?
Purpura, Thrombocytopenic, Idiopathic
1
2021
49
0.040
Why?
Autoimmunity
1
2021
173
0.040
Why?
Immunity
1
2021
189
0.040
Why?
Systemic Inflammatory Response Syndrome
1
2021
174
0.040
Why?
Immunoglobulins, Intravenous
1
2021
143
0.040
Why?
Vincristine
1
2020
195
0.040
Why?
Resource Allocation
1
2019
52
0.040
Why?
Proteome
1
2021
243
0.040
Why?
Encephalitis
1
2021
110
0.040
Why?
Datasets as Topic
1
2019
89
0.040
Why?
Interferon-gamma
1
2021
503
0.040
Why?
Proto-Oncogene Proteins
1
2022
551
0.040
Why?
Social Class
1
2019
193
0.040
Why?
Lupus Erythematosus, Systemic
1
2021
188
0.040
Why?
Cyclophosphamide
1
2020
422
0.040
Why?
B-Lymphocytes
1
2021
531
0.040
Why?
Genetic Association Studies
1
2021
777
0.040
Why?
Odds Ratio
1
2021
1252
0.040
Why?
Texas
2
2016
3592
0.040
Why?
Multiple Sclerosis
1
2021
339
0.040
Why?
Anti-HIV Agents
1
2020
315
0.030
Why?
Time Factors
2
2021
6312
0.030
Why?
Leukocytes, Mononuclear
1
2018
327
0.030
Why?
Survival Analysis
1
2020
1499
0.030
Why?
Mexico
1
2016
180
0.030
Why?
MAP Kinase Signaling System
1
2018
316
0.030
Why?
Infant, Newborn
2
2020
8189
0.030
Why?
Herpesvirus 8, Human
1
2016
49
0.030
Why?
Inhalation Exposure
1
2015
35
0.030
Why?
Housing
1
2015
59
0.030
Why?
Genetic Testing
1
2021
1004
0.030
Why?
Survival Rate
1
2019
2036
0.030
Why?
Biopsy
1
2018
1239
0.030
Why?
Disease Progression
1
2020
2052
0.030
Why?
Hematopoietic Stem Cells
1
2018
543
0.030
Why?
Risk
1
2015
757
0.030
Why?
Registries
1
2019
1422
0.030
Why?
Severity of Illness Index
1
2021
2902
0.030
Why?
Adult
3
2018
29484
0.020
Why?
Phenotype
1
2021
4260
0.020
Why?
Cohort Studies
1
2021
4786
0.020
Why?
Asymptomatic Diseases
1
2011
82
0.020
Why?
Incidental Findings
1
2011
124
0.020
Why?
Exercise Test
1
2011
251
0.020
Why?
Pacemaker, Artificial
1
2011
176
0.020
Why?
Heart Rate
1
2011
595
0.020
Why?
Patient Compliance
1
2011
475
0.020
Why?
Echocardiography
1
2012
1052
0.020
Why?
Brain
1
2018
3010
0.020
Why?
Electrocardiography
1
2011
974
0.020
Why?
Tomography, X-Ray Computed
1
2012
2092
0.010
Why?
Emergency Service, Hospital
1
2011
1091
0.010
Why?
Treatment Outcome
1
2019
12342
0.010
Why?
United States
1
2016
10876
0.010
Why?
LUBEGA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (155)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_